Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MYG1 pseudogene 1 (MYG1P1) is a non-coding pseudogene related to the protein-coding gene MYG1, located in the human genome. Unlike its parental gene, MYG1, which encodes a 3′-5′ RNA exonuclease involved in ribosomal RNA processing, mitochondrial RNA metabolism, oxidative phosphorylation, and cancer cell metabolism[1][2][3][4], MYG1P1 has no evidence of protein-coding potential or independent biological function. Pseudogenes such as MYG1P1 are generally non-functional genomic DNA fragments that arise from duplication events or retrotransposition but may occasionally have regulatory roles at the RNA level; however, there is no evidence of such a function for MYG1P1. All known disease, drug, and mechanistic associations relate to the parent gene MYG1 and not the pseudogene MYG1P1.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MYG1 pseudogene 1 (MYG1P1).